High-resolution profiling of the gut microbiome reveals the extent of Clostridium difficile burden

npj Biofilms and Microbiomes

Volumn 3, Issue 1, 2017, Pages

  Daquigan, Ninalynn ^a   Seekatz, Anna Maria ^b   Greathouse, K Leigh ^c   Young, Vincent B ^b   White, James Robert ^a  

^a Resphera Biosciences   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c BAYLOR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85042189415     PISSN: None     EISSN: 20555008     Source Type: Journal    
DOI: 10.1038/s41522-017-0043-0     Document Type: Article

References (55)

1. Leffler, D. A. & Lamont, J. T. Clostridium difficile Infection. N. Engl. J. Med. 373, 287-288 (2015).
2. Lessa, F. C. et al. Burden of Clostridium difficile infection in the United States. N. Engl. J. Med. 372, 825-834 (2015).
3. Surawicz, C. M. et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am. J. Gastroenterol. 108, 478-498 (2013).
4. Pepin, J. et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin. Infect. Dis. 40, 1591-1597 (2005).
5. Vincent, Y., Manji, A., Gregory-Miller, K. & Lee, C. A review of management of Clostridium difficile Infection: primary and recurrence. Antibiotics 4, 411-423 (2015).
6. Seekatz, A. M. & Young, V. B. Clostridium difficile and the microbiota. J. Clin. Invest. 124, 4182-4189 (2014).
7. Kelly, C. R. et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 149, 223-237 (2015).
8. Lynch, S. V. & Pedersen, O. The human intestinal microbiome in health and disease. N. Engl. J. Med. 375, 2369-2379 (2016).
9. Seekatz, A. M. et al. Recovery of the gut microbiome following fecal microbiota transplantation. MBio 5, e00893-00814 (2014).
10. Seekatz, A. M., Rao, K., Santhosh, K. & Young, V. B. Dynamics of the fecal microbiome in patients with recurrent and nonrecurrent Clostridium difficile infection. Genome Med. 8, 47 (2016).
11. Seekatz, A. M. et al. Fecal microbiota transplantation eliminates Clostridium difficile in a murine model of relapsing disease. Infect. Immun. 83, 3838-3846 (2015).
12. Zackular, J. P. et al. Dietary zinc alters the microbiota and decreases resistance to Clostridium difficile infection. Nat. Med. 22, 1330-1334 (2016).
13. Theriot, C. M. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun. 5, 3114 (2014).
14. Weingarden, A. R. et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G310-G319 (2014).
15. Buffie, C. G. et al. Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature 517, 205-208 (2015).
16. Davis, M. Y., Zhang, H., Brannan, L. E., Carman, R. J. & Boone, J. H. Rapid change of fecal microbiome and disappearance of Clostridium difficile in a colonized infant after transition from breast milk to cow milk. Microbiome 4, 53 (2016).
17. Schubert, A. M., Sinani, H. & Schloss, P. D. Antibiotic-induced alterations of the murine gut microbiota and subsequent effects on colonization resistance against Clostridium difficile. MBio 6, e00974 (2015).
18. Ottesen, A. et al. Enrichment dynamics of Listeria monocytogenes and the associated microbiome from naturally contaminated ice cream linked to a listeriosis outbreak. BMC Microbiol. 16, 275 (2016).
19. Daquigan, N., Grim, C. J., White, J. R., Hanes, D. E. & Jarvis, K. G. Early recovery of Salmonella from food using a 6-hour non-selective pre-enrichment and reformulation of tetrathionate broth. Front. Microbiol. 7, 2103 (2016).
20. Grim, C. J. et al. High-resolution microbiome profiling for detection and tracking of Salmonella enterica. Front. Microbiol. 8, 1587 (2017).
21. Khanna, S. et al. Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection. Aliment. Pharmacol. Ther. 44, 715-727 (2016).
22. Cohen, S. H. et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect. Control Hosp. Epidemiol. 31, 431-455 (2010).
23. Zhou, Y. et al. Longitudinal analysis of the premature infant intestinal microbiome prior to necrotizing enterocolitis: a case-control study. PLoS One 10, e0118632 (2015).
24. Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell. Host. Microbe 15, 382-392 (2014).
25. Furuya-Kanamori, L. et al. Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications. BMC Infect. Dis. 15, 516 (2015).
26. McNamara, S. E. et al. Carriage of Clostridium difficile and other enteric pathogens among a 4-H avocational cohort. Zoonoses Public Health 58, 192-199 (2011).
27. Miyajima, F. et al. Characterisation and carriage ratio of Clostridium difficile strains isolated from a community-dwelling elderly population in the United Kingdom. PLoS One 6, e22804 (2011).
28. Ozaki, E. et al. Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. J. Med. Microbiol. 53, 167-172 (2004).
29. Rousseau, C. et al. Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains. Clin. Infect. Dis. 55, 1209-1215 (2012).
30. Schutze, G. E. & Willoughby, R. E. Committee on infectious diseases and American academy of pediatrics. Clostridium difficile infection in infants and children. Pediatrics 131, 196-200 (2013).
31. Kim, J. et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 122, 1266-1270 (2008).
32. Cerquetti, M., Luzzi, I., Caprioli, A., Sebastianelli, A. & Mastrantonio, P. Role of Clostridium difficile in childhood diarrhea. Pediatr. Infect. Dis. J. 14, 598-603 (1995).
33. Stoesser, N. et al. Epidemiology of Clostridium difficile in infants in Oxfordshire, UK: Risk factors for colonization and carriage, and genetic overlap with regional C. difficile infection strains. PLoS One 12, e0182307 (2017).
34. Chang, T. W., Sullivan, N. M. & Wilkins, T. D. Insusceptibility of fetal intestinal mucosa and fetal cells to Clostridium difficile toxins. Zhongguo Yao Li Xue Bao 7, 448-453 (1986).
35. Eglow, R. et al. Diminished Clostridium difficile toxin A sensitivity in newborn rabbit ileum is associated with decreased toxin A receptor. J. Clin. Invest. 90, 822-829 (1992).
36. Kuiper, G. A. et al. Clostridium difficile infections in young infants: case presentations and literature review. IDCases 10, 7-11 (2017).
37. Nicholson, M. R., Thomsen, I. P. & Edwards, K. M. Controversies surrounding Clostridium difficile infection ininfants and young children. Children. 1, 40-47 (2014).
38. El Feghaly, R. E., Stauber, J. L., Tarr, P. I. & Haslam, D. B. Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections. J. Pediatr. 163, 1697-1704 (2013).
39. Wilson, K. H. & Perini, F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect. Immun. 56, 2610-2614 (1988).
40. Baumler, A. J. & Sperandio, V. Interactions between the microbiota and pathogenic bacteria in the gut. Nature 535, 85-93 (2016).
41. Greathouse, K. L., Harris, C. C. & Bultman, S. J. Dysfunctional families: Clostridium scindens and secondary bile acids inhibit the growth of Clostridium difficile. Cell. Metab. 21, 9-10 (2015).
42. Ridlon, J. M., Alves, J. M., Hylemon, P. B. & Bajaj, J. S. Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship. Gut Microbes 4, 382-387 (2013).
43. Kakiyama, G. et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J. Hepatol. 58, 949-955 (2013).
44. Theriot, C. M., Bowman, A. A. & Young, V. B. Antibiotic-induced alterations of the gut microbiota alter secondary bile acid production and allow for Clostridium difficile spore germination and outgrowth in the large intestine. mSphere 1, e00045-15 (2016).
45. Natarajan, M., Walk, S. T., Young, V. B. & Aronoff, D. M. A clinical and epidemiological review of non-toxigenic Clostridium difficile. Anaerobe 22, 1-5 (2013).
46. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120 (2014).
47. Chikhi, R. & Rizk, G. Space-efficient and exact de Bruijn graph representation based on a Bloom filter. Algorithms Mol. Biol. 8, 22 (2013).
48. Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25, 3389-3402 (1997).
49. Magoc, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957-2963 (2011).
50. Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7, 335-336 (2010).
51. Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics 27, 2194-2200 (2011).
52. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359 (2012).
53. Wang, Q., Garrity, G. M., Tiedje, J. M. & Cole, J. R. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 73, 5261-5267 (2007).
54. Abernethy, M. G. et al. Urinary microbiome and cytokine levels in women with interstitial cystitis. Obstet. Gynecol. 129, 500-506 (2017).
55. Guerrero-Preston, R. et al. High-resolution microbiome profiling uncovers Fusobacterium nucleatum, Lactobacillus gasseri/johnsonii, and Lactobacillus vaginalis associated to oral and oropharyngeal cancer in saliva from HPV positive and HPV negative patients treated with surgery and chemo-radiation. Oncotarget. https://doi.org/10.18632/oncotarget.20677 (2017).